Navigation Links
Congressman Altmire Tours Women's Health Clinical Laboratory; Learns Vital Role in Patient Care
Date:2/18/2008

PITTSBURGH, Feb. 18 /PRNewswire-USNewswire/ -- Rep. Jason Altmire (D-PA) will experience the vital and expanding role laboratory testing plays in patient care during a tour of the clinical laboratory facilities at Magee-Womens Hospital Tuesday, Feb. 19.

Pathologist R. Marshall Austin, MD, will host the 5:30 P.M. tour for Rep. Altmire, who will view a Pap test and cancer slides through a multi-headed microscope.

"Magee-Womens Hospital's ongoing leadership in improving health care for women is a great resource for western Pennsylvania," Altmire said. "This tour will give me a first hand view of the vital role Magee's medical laboratory plays in providing patients with quality health care."

Dr. Austin says the tour will illustrate the medical laboratory's role as a key element of patient care and show how laboratory results provide a crucial thread that runs through the entire patient care process.

"Laboratory test results drive a significant portion of clinical decisions, from diagnosis to therapy," said Dr. Austin. "This tour will underscore how the medical laboratory contributes to the maintenance of wellness, the diagnosis of illness and the treatment of disease."

Magee-Womens Hospital laboratory is the largest academic cytology laboratory in the U.S. performing over 100,000 Pap tests annually on women from Western Pennsylvania. The pathology department contains an unusual group of highly specialized pathologists dedicated specifically to work exploring and advancing the study of gynecologic and breast diseases. Many innovative women's health research projects are ongoing in this department. In addition, the 50-year-old School of Cytology is one of the oldest in the country and has long-trained cancer screening personnel for the region.

The College of American Pathologists (CAP) is a medical society serving 17,000 physician members and the laboratory community throughout the world. It is the world's large
'/>"/>

SOURCE College of American Pathologists
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Congressman Hoekstra Tours Holland Pathology Laboratory; Learns Vital Role In Patient Care
2. Susan G. Komen for the Cure, U.S. Congressman Pat Tiberi, Ohio Senator Tom Niehaus, and OhioHealth Riverside Breast Health Center Call for Action on Breast Cancer
3. Congressman Davis to Tour Pathology Laboratory, Learn Critical Role in Patient Care
4. Champion of blinded soldiers, Congressman Murtha, is Man of Vision
5. Congressman Tom Reynolds Awarded for Protecting Medicare Choices
6. AMWA Hosts Health Care Conversation With Congressman Kucinich
7. Former Congressman Hyde Awarded Presidential Medal of Freedom While Receiving Medical Rehabilitation at Marianjoy
8. QueensLander Tours Presents an Adventure Boot Camp Cruise with John Spencer Ellis from Bravos The Real Housewives of Orange County
9. Every Baby Has a Story Campaign Tours the Nation for March of Dimes
10. Greenway Medical Technologies Broadens Sales Efforts With Entrance Into Federally Qualified Health Center Marketplace
11. Oceans, coasts and your health: Reducing risks and reaping rewards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)...c. 4 Aurora Health Care is ramping...upplements. Aurora,s Care Management,Clinical Lea...e all Aurora,caregivers about the benefits of Vit...idence that higher Vitamin D levels may improve ou...sis, certain muscle conditions and,seasonal depre...
(Date:12/4/2008)...as, Dec. 4 MiddleBrook,...ounced that it has opened its,administrative and ...rmantown,facility will continue to house certain ...research and development group. The newly leased ...to house up to 60 employees as MiddleBrook,grows....
(Date:12/4/2008)...ch., Dec. 4 BAPTIST HEALTH, a six-...he state,s largest health system, has,expanded it... Reuters -- a,solution that enabled the system,s ...entions and save more than $1 million. , "D... campus show that,CareFocus prompts approximately...
(Date:12/4/2008)...similar to those seen with standard dose of daunor... (HealthDay News) -- A high dose of the chemothera...ts with previously untreated acute myeloid leukemi...by the U.S. National Cancer Institute (NCI) show. ... This study included 633 patients, aged 16 to 60, ...
Breaking Medicine News(10 mins):Health News:Aurora Health Care Urges All Wisconsin Residents to Take Vitamin D 2Health News:Middlebrook Pharmaceuticals Opens Administrative and Sales Office in Westlake, Texas 2Health News:Middlebrook Pharmaceuticals Opens Administrative and Sales Office in Westlake, Texas 3Health News:Middlebrook Pharmaceuticals Opens Administrative and Sales Office in Westlake, Texas 4Health News:BAPTIST HEALTH Uses Real-Time Clinical Surveillance from Thomson Reuters to Lower Costs and Improve Quality in the Pharmacy 2Health News:BAPTIST HEALTH Uses Real-Time Clinical Surveillance from Thomson Reuters to Lower Costs and Improve Quality in the Pharmacy 3Health News:Higher Chemo Drug Dose Prolongs Lives of Leukemia Patients 2
...ans for the Northeast have been announced by the H...is expected to be opened by 2015//. The five exis...d in Dundalk, Drogheda, Navan, Monaghan. and Cavan... Walsh at Monaghan General Hospital last year cons...
...Municipal Corporation’s (BMC) Health Committee had...d conducted health camps// Chamunda Nagar and Shya...on have been reported. Their report has concluded ...te survey conducted by an NGO, Bal Hakk Abhiyan (B...
...e July 15 issue of Clinical Infectious Diseases sa...s could be very useful// in the event of an influe...atins lower "bad" cholesterol levels in the blood ... cholesterol. Statins may further protect the hear...
...he medicos who had resorted to the strike against ...h Minister Anbumani Ramadoss today said that not p...as not a punishment. 'It is not a punitive action....elease the salaries, we will do so,' he told repor...
Other Medicine News:Health News:Children In Slums Of Mumbai Might be Suffering From Malnutrition 2Health News:Statins Could Play Important Role In Influenza Pandemic 2
(Date:12/3/2008)...3 Wyeth Pharmaceuticals,...day that it has submitted a,marketing authorizati...ncy,(EMEA) for approval to market its investigati...V13) for infants and young children. Wyeth is see...ccal disease (PD) caused by the 13,serotypes incl...
(Date:12/2/2008)...ire-USNewswire/ -- Researchers using functional,M...e area of the brain,responsible for suppressing m...,stress-related psychiatric disorders. Results of ...eeting of the Radiological Society of North Americ...ssion and other stress-related disorders,traumat...
(Date:12/2/2008)...Newswire/ -- Horizon Therapeutics, Inc., a,privat...d that two pivotal,Phase 3 trials evaluating its ...met all primary endpoints. HZT-501, a novel, propr...ibuprofen and famotidine, demonstrated a,statisti...n-steroidal,anti-inflammatory drug (NSAID)-induce...
(Date:12/1/2008)...swire/ -- TargeGen has announced that an oral,pre...ter, US-based clinical,trial of TG101348 in myelo...at,the 2008 American Society of Hematology (ASH) ...e as follows:, Title: A Phase I... JAK2-Selective Inhibitor, in Pat...
Breaking Medicine Technology:Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children 2Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children 3Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children 4Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children 5Stress-Related Disorders Affect Brain's Processing of Memory 2Stress-Related Disorders Affect Brain's Processing of Memory 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4Plexus Systems Inc and Aberdeen Group Co host March 27 Webinar on Manufacturing Efficiency 15096 1Plexus Systems Inc and Aberdeen Group Co host March 27 Webinar on Manufacturing Efficiency 15096 2Plexus Systems Inc and Aberdeen Group Co host March 27 Webinar on Manufacturing Efficiency 15096 3MRI Can Be Predictor of Post Treatment Prostate Cancer Spread 15095 1MRI Can Be Predictor of Post Treatment Prostate Cancer Spread 15095 2Mounting evidence shows red wine antioxidant kills cancer 2618 1Mounting evidence shows red wine antioxidant kills cancer 2618 2Mounting evidence shows red wine antioxidant kills cancer 2618 3New York City Staffing Company Charged With Violating H 1B Program Following U S Labor Department Finding Almost 243 Million in Back Wages Due 156 W 15090 1New York City Staffing Company Charged With Violating H 1B Program Following U S Labor Department Finding Almost 243 Million in Back Wages Due 156 W 15090 2
...ne Plus Minocycline Showed Substantial,Reduction o...ng-Remitting Multiple Sclerosis , Combination Trea...s and Was Well Tolerated , KANSAS CITY, Mo, May 4,...tudy showed that a combination of Copaxone,(glatir...otic,minocycline reduced T1 Gadolinium (Gd)-enhanc...
...th May 2007 - CeNeS Pharmaceuticals plc,(LSE: CEN)...otes,the publication of an independent study in th...hase II NMDA antagonist, CNS 5161. CeNeS,is develo...thic,pain. The independent study builds on the wor... , In the study reported in ,Synapse, Dr Anat Bie...
Other Medicine Technology:Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 2Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 3Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 4Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 5Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 6Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 7Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 8Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 9Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 10Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 11Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 12Independent publication supports the profile of CeNeS phase II,compound, CNS 5161 2Independent publication supports the profile of CeNeS phase II,compound, CNS 5161 3
Large solid mallet with patented Ortho-Grip® silicone rubber handle.
Angled ring curette.
Perisoteal rasp for elevating, dissecting, and scraping.
Stainless steel bone clamp.
Medicine Products: